PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7675115-0	1995	Beta-adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting beta 2-adrenoceptor agonist formoterol.	Formoterol Fumarate	152-162	beta-2 adrenergic receptor	Cavia porcellus	124-143	
10763855-1	2000	The long-acting beta2-adrenoceptor agonist formoterol is, like all other members of this class of drugs, used as a racemate in the clinic.	Formoterol Fumarate	43-53	beta-2 adrenergic receptor	Cavia porcellus	16-34	
7675115-1	1995	Formoterol is a long acting beta 2-adrenoceptor agonist designed for the alleviation of the symptoms of asthma.	Formoterol Fumarate	0-10	beta-2 adrenergic receptor	Cavia porcellus	28-47	
7675115-5	1995	Formoterol treatment produced marked reductions of between 43% and 77% in beta 2-adrenoceptor density in all regions of the heart (atrioventricular node, bundle of His, right and left bundle branches, interventricular and interatrial septa, right and left atria, ventricles and apex) and lung (bronchial and vascular smooth muscle and parenchyma) (P < 0.01, n = 6).	Formoterol Fumarate	0-10	beta-2 adrenergic receptor	Cavia porcellus	74-93	
1360770-1	1992	Formoterol and salmeterol are 2 newly developed beta 2-adrenoceptor agonists for inhalation with prolonged duration of effect compared with currently available beta 2-agonists.	Formoterol Fumarate	0-10	beta-2 adrenergic receptor	Cavia porcellus	48-67	
29987243-2	2018	Muscarinic receptor antagonists (tiotropium, glycopyrronium, atropine) synergistically enhanced the relaxant effects of beta2-adrenergic receptor agonists (procaterol, salbutamol, formoterol) in guinea pig trachealis.	Formoterol Fumarate	180-190	beta-2 adrenergic receptor	Cavia porcellus	120-145	
8100652-1	1993	BACKGROUND: Formoterol and salmeterol are new long acting beta 2 adrenoceptor agonists.	Formoterol Fumarate	12-22	beta-2 adrenergic receptor	Cavia porcellus	58-77